Evidence map›Paper›PMID 42656789›Full record

ArticleFrontiers in microbiology2026

MRSA in Tibet: high prevalence driven by the epidemic clone CC59-ST59-SCC

Wei Li, Yichuan Qiu, Xiaodong Wu, Jinmei Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wei LiDepartment of Pediatric Cardiovascular Surgery, Children's Heart Center, West China Second University Hospital, Sichuan University, Chengdu, China.
Yichuan QiuDepartment of Clinical Laboratory, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, China.
Xiaodong WuChangdu People's Hospital of Xizang, Changdu, China.
Jinmei ZhangDepartment of Pediatric Cardiovascular Surgery, Children's Heart Center, West China Second University Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Methicillin-resistant Methods: We analyzed 115 non-duplicate MRSA isolates from Tibetans, comprising 51 hospital-associated MRSA (HA-MRSA) from clinical infections and 64 community-colonizing MRSA (CA-MRSA). CA-MRSA isolates were obtained from nasal swabs of hospitalized patients within 24 h of admission (to exclude nosocomial acquisition) and from their family members between June and December 2023. All isolates underwent antimicrobial susceptibility testing and whole-genome sequencing (WGS)-based typing [sequence type (ST), Results: The MRSA nasal colonization rate was 10.53%. The clone CC59-ST59-SCC Conclusion: CC59-ST59-SCC

Indexed as

CA-MRSAHA-MRSAmolecular epidemiologyTibetansvirulencewhole-genome sequencing

Identifiers

PMID42656789
PMCPMC13506926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.